G.J. Creemers

7.6k citations

46 papers · 1.6k indexed · h-index 23

Oncology top 2%
- Colorectal Cancer Treatments and Studies 15
- Colorectal Cancer Surgical Treatments 10
- Cancer Treatment and Pharmacology 5
- Neutropenia and Cancer Infections 5
Cancer Research top 10%
Pulmonary and Respiratory Medicine top 5%
- Gastric Cancer Management and Outcomes 9
Hepatology top 10%
Reproductive Medicine top 10%
Surgery
- Colorectal and Anal Carcinomas 9
- Esophageal Cancer Research and Treatment 5
Molecular Biology
- Cancer therapeutics and mechanisms 7

Co-authors: Jaap Verweij Birthe Lund V.E.P.P. Lemmens H.J.T. Rutten Cornelis J.A. Punt Miriam Koopman Ignace H. J. T. de Hingh M de Boer-Dennert
Cited by: Oncology Cancer Research Pulmonary and Respiratory Medicine
Journals: Journal of Clinical Oncology (2 papers)Scientific Reports (1 paper)British Journal of Cancer (3 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

G.J. Creemers

45 papers receiving 1.5k citations

Peers

Countries citing papers authored by G.J. Creemers

Since Specialization

Citations

This map shows the geographic impact of G.J. Creemers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.J. Creemers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.J. Creemers more than expected).

Fields of papers citing papers by G.J. Creemers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.J. Creemers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.J. Creemers. The network helps show where G.J. Creemers may publish in the future.

Co-authorship network

The 25 scholars most cited alongside G.J. Creemers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with G.J. Creemers Line = papers co-authored together G.J. Creemers links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study European Journal of Surgical Oncology ·Robin J. Lurvink,Checca Bakkers,Anouk Rijken,Felice N. van Erning,Simon W. Nienhuijs,Jacobus W. A. Burger,G.J. Creemers,C. Verhoef,V.E.P.P. Lemmens,Ignace H. J. T. de Hingh	2020	49
2	Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study Annals of Oncology ·Kaitlyn K.H. Goey,Sjoerd G. Elias,Harm van Tinteren,Miangela M. Laclé,Stefan M. Willems,G.J.A. Offerhaus,Wendy W.J. de Leng,E Strengman,Albert J. ten Tije,G.J. Creemers,A. van der Velden,Felix E. de Jongh,Frans Erdkamp,Bea C. Tanis,Cornelis J.A. Punt,Miriam Koopman	2017	56
3	Impact of sarcopenia on dose limiting toxicities in metastatic colorectal cancer patients (mCRC pts) receiving palliative systemic treatment Annals of Oncology ·Sophie A. Kurk,Petra H.M. Peeters,Rebecca K. Stellato,Bram Dorresteijn,Marion Jourdan,G.J. Creemers,Frans Erdkamp,FE de Jongh,P. Kint,Boelo Jan Poppema,Sandra A. Radema,Lieke H. J. Simkens,Bea C. Tanis,Manuel L. R. Tjin‐A‐Ton,A. van der Velden,Cornelis J.A. Punt,Miriam Koopman,Anne M. May	2017	3
4	Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group Annals of Oncology ·Johannes J.M. Kwakman,Lieke H. J. Simkens,Johan M. van Rooijen,Agnès J. van de Wouw,Albert J. ten Tije,G.J. Creemers,Mathijs P. Hendriks,Maartje Los,R J van Alphen,M. Polée,E.W. Muller,Ankie M.T. van der Velden,Theo van Voorthuizen,Miriam Koopman,Linda Mol,Erik van Werkhoven,Cornelis J.A. Punt	2017	47
5	Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer European Journal of Cancer ·Mira D. Franken,E.M. van Rooijen,Anne M. May,Hendrik Koffijberg,Harm van Tinteren,Linda Mol,Albert J. ten Tije,G.J. Creemers,Ankie M.T. van der Velden,Bea C. Tanis,Carin A. Uyl‐de Groot,Cornelis J.A. Punt,Miriam Koopman,Martijn G.H. van Oijen	2017	19
6	Bevacizumab for metachronous metastatic colorectal cancer: a reflection of community based practice BMC Cancer ·Lieke G.E.M. Razenberg,Yvette R.B.M. van Gestel,Ignace H. J. T. de Hingh,O. J. L. Loosveld,Gerard Vreugdenhil,Laurens V. Beerepoot,G.J. Creemers,V.E.P.P. Lemmens	2016	7
7	Developing a core set of patient-reported outcomes in pancreatic cancer: A delphi survey HPB ·Arja Gerritsen,M. Jacobs,Inge Henselmans,J Van Hattum,G.J. Creemers,Ignace H. J. T. de Hingh,M. Kooperman,I. Quintus Molenaar,Johanna W. Wilmink,Olivier R. Busch,Marc G. Besselink,Hanneke W.M. van Laarhoven	2016	4
8	Increased Survival of Patients with Synchronous Colorectal Peritoneal Metastases Receiving Preoperative Chemotherapy Before Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Annals of Surgical Oncology ·Robin A C Devilee,Geert A. Simkens,Thijs R. van Oudheusden,H.J.T. Rutten,G.J. Creemers,Albert J. ten Tije,Ignace H. J. T. de Hingh	2016	34
9	Systemic treatment of patients with metachronous peritoneal carcinomatosis of colorectal origin Scientific Reports ·Thijs R. van Oudheusden,Lieke G.E.M. Razenberg,Yvette R. van Gestel,G.J. Creemers,V.E.P.P. Lemmens,Ignace H. J. T. de Hingh	2015	20
10	Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro) European Journal of Cancer ·Hielke J. Meulenbeld,Erik van Werkhoven,J.L. Coenen,G.J. Creemers,O. J. L. Loosveld,P.C. de Jong,Albert J. ten Tije,Sophie D. Fosså,M. Polée,Winald R. Gerritsen,Otilia Dalesio,Ronald de Wit	2012	31
11	Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: A population-based study in the Netherlands European Journal of Cancer ·Anneriet E. Dassen,V.E.P.P. Lemmens,Lonneke V. van de Poll‐Franse,G.J. Creemers,S.J. Brenninkmeijer,Daan J. Lips,A.A.M. vd Wurff,Koop Bosscha,J.W.W. Coebergh	2010	118
12	Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents Annals of Oncology ·J. Tol,Miriam Koopman,Michael Craig Miller,Arjan G.J. Tibbe,Annemieke Cats,G.J. Creemers,Allert H. Vos,Irıs D. Nagtegaal,Leon W.M.M. Terstappen,Cornelis J.A. Punt	2009	178
13	Significant improvement in survival of patients presenting with metastatic colon cancer in the south of The Netherlands from 1990 to 2004 Annals of Oncology ·Hielke J. Meulenbeld,Liza N. van Steenbergen,M.L.G. Janssen‐Heijnen,V.E.P.P. Lemmens,G.J. Creemers	2008	40
14	A Highly Active and Tolerable Neoadjuvant Regimen Combining Paclitaxel, Carboplatin, 5-FU, and Radiation Therapy in Patients with Stage II and III Esophageal Cancer Annals of Surgical Oncology ·L. van de Schoot,Elisabeth APM Romme,Maurice J.C. van der Sangen,G.J. Creemers,Gesina van Lijnschoten,O.J. Repelaer van Driel,H.J.T. Rutten,Grard A. P. Nieuwenhuijzen	2007	17
15	Randomised Phase III study of biweekly 24-h infusion of high-dose 5FU with folinic acid and oxaliplatin versus monthly plus 5-FU/folinic acid in first-line treatment of advanced colorectal cancer Annals of Oncology ·Geke A.P. Hospers,Michael Schaapveld,J.W.R. Nortier,J. Wils,Aart van Bochove,Robert S. de Jong,G.J. Creemers,Z. Erjavec,D. J. de Gooyer,P. H. Th. J. Slee,C J Gerrits,Jeff M. Smit,Nanno H. Mulder	2006	29
16	Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors. Journal of Clinical Oncology ·G.J. Creemers,C J Gerrits,John R. Eckardt,Jan H.M. Schellens,Howard A. Burris,André Planting,G I Rodriguez,Walter J. Loos,I Hudson,Colin Broom,Jaap Verweij,Daniel D. Von Hoff	1997	66
17	The bioavailability of oral GI147211 (GG211), a new topoisomerase I inhibitor British Journal of Cancer ·CJH Gerrits,JHM Schellens,G.J. Creemers,Paul Wissel,A.S.T. Planting,J. Fred Pritchard,Scott Depee,M de Boer-Dennert,Miranda Harteveld,Jaap Verweij	1997	24
18	Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor British Journal of Cancer ·JHM Schellens,G.J. Creemers,Jos H. Beijnen,Hilde Rosing,M de Boer-Dennert,Mirna McDonald,B. E. Davies,Jaap Verweij	1996	113
19	Phase I and pharmacological study of the new topoisomerase I inhibitor GI147211, using a daily x 5 intravenous administration British Journal of Cancer ·CJH Gerrits,G.J. Creemers,JHM Schellens,Paul Wissel,AS Planting,Robert L. Kunka,K. Selinger,M de Boer-Dennert,Y Marijnen,Miranda Harteveld,Jaap Verweij	1996	37
20	Topoisomerase I inhibitors: topotecan and irenotecan Cancer Treatment Reviews ·G.J. Creemers,Birthe Lund,Jaap Verweij	1994	218

About G.J. Creemers

G.J. Creemers is a scholar working on Oncology, Surgery and Emergency Medicine, having authored 46 papers that have together received 1.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (15 papers), Colorectal Cancer Surgical Treatments (10 papers), Colorectal and Anal Carcinomas (9 papers), Gastric Cancer Management and Outcomes (9 papers), Cancer therapeutics and mechanisms (7 papers), Cancer Treatment and Pharmacology (5 papers), Esophageal Cancer Research and Treatment (5 papers) and Neutropenia and Cancer Infections (5 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (222 citations) and Pulmonary and Respiratory Medicine (393 citations). G.J. Creemers has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Jaap Verweij, Birthe Lund, V.E.P.P. Lemmens, H.J.T. Rutten, Cornelis J.A. Punt, Miriam Koopman, Ignace H. J. T. de Hingh, M de Boer-Dennert, Grard A. P. Nieuwenhuijzen and JHM Schellens. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact